The Fleming Initiative, a partnership between Imperial College London and Imperial College Healthcare NHS Trust, is receiving technical support worth several million pounds from Amazon Web Services (AWS) to build a global intelligence platform against antimicrobial resistance (AMR), a condition responsible for a predicted 39 million deaths between 2025 and 2050.
A Fragmented Fight Against a Growing Threat
AMR occurs when mutating microorganisms render standard treatments ineffective, and it remains one of the biggest global public health challenges. Progress against it has been slow, held back by fragmented surveillance systems, siloed research efforts, and limited access to integrated, real-world data across healthcare, laboratory, and community settings.
Speaking at the One Health Summit in Lyon, held under France's G7 presidency, Professor the Lord Darzi of Denham, Executive Chair of the Fleming Initiative, described the scale of the challenge as a vast, interconnected web of data made up of millions or even billions of individual signals.
"By pairing world-leading scientific expertise with the most advanced technology available, we can build a new generation of intelligence for AMR."— Professor the Lord Darzi of Denham, Executive Chair, Fleming Initiative
Unifying the World's Fragmented AMR Data
Using AWS's generative AI and cloud services, the Fleming Initiative is bringing together some of the world's most fragmented AMR datasets, including compound libraries and surveillance signals, onto a single cloud-based platform for the first time. The goal is to surface patterns that have stayed invisible while scattered across institutional silos and national borders.
Professor Alison Holmes, Director of the Fleming Initiative, notes that AMR is a global challenge no single institution, country, or dataset can solve on its own, and that the AWS partnership could help connect expertise, data, and technology in previously unavailable ways. The resulting infrastructure is designed to function as a living intelligence platform that grows stronger as more institutions contribute data, supporting researchers, healthcare organizations, industry, and policymakers collaborating across borders, while also building local and regional capacity for AMR surveillance and response.
